23 May 2024
An exciting milestone in our pursuit to make CAR T-cell therapy a standard of care in New Zealand, the Environmental Protection Authority NZ has approved use of chimeric antigen receptor (CAR) T-cells in our phase 2 clinical trial with BioOra.
As a trial of this kind had never been done before in New Zealand, our team has put significant time and effort into working with national regulatory bodies such as the EPA and MedSafe to navigate and establish the necessary regulatory pathways to bring CAR T-cell technology to New Zealand.
In doing so, we have opened doors for similar life-saving cell therapy trials to be undertaken here in the future - whether our own or others.
Related articles
New Zealand has a chance to lead in next-generation cancer treatments
11 March 2026
CAR T-cell therapy: 5-part video series
25 February 2026
Momentum is everything: advancing CAR T-cell research for future trials and treatments
25 February 2026
A ground-breaking cancer treatment is within reach – but only if New Zealand acts now
12 February 2026
Homegrown Hope - Stuff's series on CAR T-cell therapy
11 February 2026
Celebrating milestones in bringing life-saving cell therapies to New Zealand
12 November 2025